ZK-Epo Given With Prednisone in Patients With Metastatic Androgen-independent Prostate Cancer
NCT00350051
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
53
Enrollment
INDUSTRY
Sponsor class
Conditions
Prostate Cancer
Interventions
DRUG:
Sagopilone (ZK 219477) + prednisone
Sponsor
Bayer